By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50



Gene Therapy

Company News
Mologen AG (MOLGF.PK): Progress In Clinical Trials Sets First Quarter Trend 5/12/2015 8:44:23 AM
Mologen AG (MOLGF.PK): Aarhus University Hospital Initiates MGN1703 Study In HIV Patients 5/8/2015 8:50:09 AM
Mologen AG (MOLGF.PK) Presented Data Supporting The Administration Scheme Of MGN1703 At ITOC-2 Conference 2015 3/30/2015 9:08:25 AM
Mologen AG (MOLGF.PK): Start Of Pivotal Study For Cancer Immunotherapy MGN1703 Influences 2014 Annual Result 3/25/2015 9:56:22 AM
Mologen AG (MOLGF.PK) Presented Subgroup Analysis From IMPACT Study And Design Of Pivotal IMPALA Trial At Gastrointestinal Cancers Symposium 2015 1/19/2015 10:13:03 AM
Mologen AG (MOLGF.PK): Presentation On IMPACT Study At ESMO Symposium On Immuno-Oncology 11/17/2014 1:27:53 PM
Mologen AG (MOLGF.PK) Publishes Nine Month Report For 2014: Launch Of Pivotal Study For The Cancer Immunotherapy MGN1703 11/13/2014 9:51:51 AM
Mologen AG (MOLGF.PK): Presentation Of DNA Vaccine Against Leishmaniasis At IMED 2014 11/3/2014 12:54:28 PM
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014 11:08:34 AM
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014 10:53:05 AM